ArticleActa neuropathologica communications2021

The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents.

Sebastian Siller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.